Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bavarian, mpox vaccine
EMA approves Bavarian Nordic’s mpox vaccine for teenagers
The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the chances for its use in this age group in Africa. The label extension is via a type II variation – a route used when a major change is needed in the marketing authorisation for a medicine approved in Europe.
Bavarian Nordic mpox shot gains approval for adolescents in EU
The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 years old. Approval was based on data from a clinical study of more than 300 adolescents and 200 adults that found non-inferior immune responses and similar safety profile between both age groups after two standard doses
EU Approves Use of Bavarian Nordic's Mpox Vaccine for Adolescents
Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as essential for containing an outbreak in parts of Africa, with the World Health Organization declaring mpox a global public health emergency.
Bavarian Gets EU Approval for Mpox Vaccine for Adolescents
Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe for the use of its jab for adolescents.
Bavarian Nordic Gets EMA Approval Of Mpox Vaccine For Adolescents
(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II variation for IMVANEX smallpox and mpox vaccine. This extends the current marketing authorization to include adolescents 12 to 17 years of age.
EU approves Bavarian Nordic's mpox vaccine for adolescents
Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday.
EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents
EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents: Copengagen, Denmark Saturday, September 21, 2024, 10:00 Hrs [IST] Bavarian Nordic A/S, a
Gavi to obtain 500,000 mpox vaccine doses from Bavarian Nordic
Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to secure 500,000 doses of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN) mpox vaccine. The vaccines, marketed under names including JYNNEOS and IMVANEX, are intended for supply in African countries.
The New York Times
4d
Bavarian Nordic AS
The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak. By Stephanie Nolen Drugmakers have supplies ready to ship that are necessary to ...
FiercePharma
2d
Gavi, UK government tap Bavarian Nordic for 650,000 doses of mpox vaccine
Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...
5h
Twin studies show Bavarian Nordic’s Mpox vax efficacy wanes in 1 year
Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Secret Service admits failure
Actress Crosby dies at 90
Ga. suspect's mom indicted
Accepts CNN debate invite
Russia threatens retaliation
Feds subpoena Schaeffer
Pandas leaving for China
Drug price challenge revived
WI high court to decide
SC 1st execution in 13 years
Released after guilty plea
Boeing defense chief exits
Biden hosts 'Quad' summit
House repeals emission rules
Sesame Place suit verdict
Hiker injured in bear attack
Stein's ballot bid rejected
FDA approves flu vaccine
1st rabies outbreak in seals
Sues pharmacy middlemen
144K+ Mavericks recalled
FBI agents board vessel
$230 million crypto theft
TN abortion law blocked
Hand count approved in GA
Top Hezbollah leader killed?
J&J unit files for bankruptcy
CA bill to protect kids online
Disney to stop using Slack
Bill to boost security OK'd
Beirut strike death toll
Rallies in North Carolina
In-person voting begins
ISR strike on Gaza school
Feedback